Endoscopic Therapeutic Option for Weight Loss and Control of Type 2 XXXX : the Duodenal-Jejunal Bypass Liner.

@entity1 @entity101 @entity28 @entity2299 @entity6 @entity353 @entity413 @entity1561 @entity164 @entity209 @entity204 @entity65
For a long time, @entity28 has been known as a risk factor for @entity65 , which is one of the main causes of @entity204 in developed countries. This risk is due to the coexistence of other factors associated with @entity28 , such as @entity101 , @entity2299 , @entity1561 , and @entity209 . @entity28 is also a major risk factor for @entity164 2 @entity6 , and it is not surprising that the global prevalence of this disease continues to increase. Surgical intervention is now the most effective modality to treat severe @entity28 and its comorbidities. However, endoluminal interventions performed entirely through the gastrointestinal tract by using endoscopic devices offer the potential for an outpatient @entity353 procedure that may be safer, less invasive, and more cost-effective, compared with current surgical approaches. Given the emerging role of endoscopic procedures in the treatment of @entity28 and rapid changes in endoscopic technologies and techniques, this review considers the current state of endoscopic management of @entity28 and @entity164 2 @entity6 . Endoscopic techniques attempt to mimic some of the anatomic features of bariatric surgery and rely on gastric restriction and duodenal exclusion. The endoscopic placement of the duodenal-jejunal bypass liner in morbidly @entity28 @entity1 induces significant @entity353 . Additionally, early studies reported significant improvements in several parameters of @entity413 homeostasis in morbidly @entity28 @entity1 with @entity164 2 @entity6 . In this article we will review the available results obtained with the duodenal-jejunal bypass liner.
